The authors of "Selective requirement of MYB for oncogenic hyperac…" (https://t.co/Dv7Jm8zktH) included RRIDs in their paper! We appreciate the author's support of reproducibility. #STMpublishing #reproducibility
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
From the November issue: Selective requirement of #MYB for oncogenic hyperactivation of a translocated #enhancer in #leukemia. https://t.co/F7C5Lrv6pr. Ruud Delwel et al. @SmeenkLeonie @johannes_zuber @oncodeinstitute @ErasmusMC @IMPvienna @viennabiocenter
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
Congrats! Looking forward to this today.
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
RT @DelwelRuud: Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered…
Today, Leonie Smeenk's paper is out in "Cancer Discovery". A new chapter in our understanding of the mechanisms of altered oncogene activation by hijacked enhancers in Leukemia. https://t.co/1fOR9jPewX https://t.co/NWcceplima
RT @KentsisResearch: @DanielleHammo20 @AaronGoodman33 Working on it, see this recent paper from Ruud Delwel and colleagues for a new therap…
@DanielleHammo20 @AaronGoodman33 Working on it, see this recent paper from Ruud Delwel and colleagues for a new therapeutic strategy that needs clinical development: https://t.co/Uq6MFKNYem
RT @CancerCureNow: Selective requirement of MYB for oncogenic hyperactivation of a translocated enhancer in leukemia https://t.co/OBXaVCPaO1
Selective requirement of MYB for oncogenic hyperactivation of a translocated enhancer in leukemia https://t.co/OBXaVCPaO1
RT @Hema_News: Published in @CD_AACR! Investigators from @erasmusmcintl generated an EVI1-GFP #AML model and applied an unbiased #CRISPR/C…
RT @Hema_News: Published in @CD_AACR! Investigators from @erasmusmcintl generated an EVI1-GFP #AML model and applied an unbiased #CRISPR/C…
RT @Hema_News: Published in @CD_AACR! Investigators from @erasmusmcintl generated an EVI1-GFP #AML model and applied an unbiased #CRISPR/C…
RT @JianXuLab: Very interesting findings👇MYB seems to the ultimate answer to most (if not all) ‘oncogenic’ enhancers in leukemia! https://t…
RT @Hema_News: Published in @CD_AACR! Investigators from @erasmusmcintl generated an EVI1-GFP #AML model and applied an unbiased #CRISPR/C…
RT @Hema_News: Published in @CD_AACR! Investigators from @erasmusmcintl generated an EVI1-GFP #AML model and applied an unbiased #CRISPR/C…
Published in @CD_AACR! Investigators from @erasmusmcintl generated an EVI1-GFP #AML model and applied an unbiased #CRISPR/Cas9 enhancer scan to uncover sequence motifs essential for EVI1 transcription. #leukemia https://t.co/J7aF23XnJj https://t.co/4ng3V
New article: Selective requirement of MYB for oncogenic hyperactivation of a translocated enhancer in leukemia https://t.co/yLQA2ju682 #AML #leusm #hematology https://t.co/v2Gzs1NLdD
RT @JianXuLab: Very interesting findings👇MYB seems to the ultimate answer to most (if not all) ‘oncogenic’ enhancers in leukemia!
RT @SmeenkLeonie: Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @…
RT @JianXuLab: Very interesting findings👇MYB seems to the ultimate answer to most (if not all) ‘oncogenic’ enhancers in leukemia!
Very interesting findings👇MYB seems to the ultimate answer to most (if not all) ‘oncogenic’ enhancers in leukemia!
RT @SmeenkLeonie: Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @…
RT @SmeenkLeonie: Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @…
RT @ElizSMcKenna: Now online in @CD_AACR: Selective requirement of #MYB for oncogenic hyperactivation of a translocated #enhancer in #leuke…
RT @SmeenkLeonie: Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @…
RT @ElizSMcKenna: Now online in @CD_AACR: Selective requirement of #MYB for oncogenic hyperactivation of a translocated #enhancer in #leuke…
RT @SmeenkLeonie: Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @…
RT @SmeenkLeonie: Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @…
RT @SmeenkLeonie: Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @…
Very happy to share our latest study which is out now in @CD_AACR. Thanks to amazing team work and great collaborations @johannes_zuber, @KentsisResearch and @emerybresnick!
#OnlineFirst: Selective requirement of #MYB for oncogenic hyperactivation of a translocated #enhancer in #leukemia by @SmeenkLeonie @johannes_zuber Ruud Delwel and colleagues. @oncodeinstitute @ErasmusMC @IMPvienna @viennabiocenter https://t.co/J9W6FfZ3t5
RT @ElizSMcKenna: Now online in @CD_AACR: Selective requirement of #MYB for oncogenic hyperactivation of a translocated #enhancer in #leuke…
Now online in @CD_AACR: Selective requirement of #MYB for oncogenic hyperactivation of a translocated #enhancer in #leukemia by @SmeenkLeonie @johannes_zuber Ruud Delwel and colleagues @oncodeinstitute @ErasmusMC @IMPvienna @viennabiocenter https://t.co/3u